STOCK TITAN
  1. Home
  2. Sec-filings
  3. LAB
  4. [8-K] STANDARD BIOTOOLS INC. Reports Material Event

Standard BioTools (NASDAQ: LAB) back in compliance with Nasdaq bid rule

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Standard BioTools Inc. has regained compliance with Nasdaq’s minimum bid price rule. On June 5, 2026, the company received notice from Nasdaq’s Listing Qualifications Staff confirming that it now meets Nasdaq Listing Rule 5450(a)(1), which requires a bid price of at least $1.00 per share. The issue arose after an April 20, 2026 notice that the company’s common stock had closed below $1.00 for 30 consecutive business days. Nasdaq has now closed this matter, and the company’s common stock continues to trade on the Nasdaq Global Select Market under the symbol LAB.

Positive

  • None.

Negative

  • None.

Insights

Regaining Nasdaq bid-price compliance removes near-term delisting risk.

Standard BioTools Inc. received confirmation on June 5, 2026 that it again satisfies Nasdaq Listing Rule 5450(a)(1), the minimum $1.00 bid price standard. This follows an April notice triggered by 30 consecutive trading days below the threshold.

Maintaining compliance keeps the shares on the Nasdaq Global Select Market, avoiding forced moves to lower tiers or over-the-counter trading. That stability can matter for liquidity and institutional ownership, though the confirmation itself does not change the company’s operations or financials.

Future disclosures in company filings may indicate whether any corporate actions, such as price-supporting measures, contributed to regaining compliance, but this excerpt simply states that the prior deficiency matter is now closed.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Minimum bid price threshold $1.00 per share Nasdaq Listing Rule 5450(a)(1) Bid Price Requirement
Deficiency notice date April 20, 2026 Nasdaq notice of bid price non-compliance
Regained compliance date June 5, 2026 Nasdaq confirmation of compliance with Bid Price Requirement
Consecutive days below threshold 30 business days Period with closing bid price under $1.00 per share
Nasdaq Listing Rule 5450(a)(1) regulatory
"indicating that it has regained compliance with Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”)"
Nasdaq Listing Rule 5450(a)(1) is a continued-listing standard that sets a minimum share price companies must maintain to remain listed on the Nasdaq market—commonly a $1.00 per-share threshold. Investors care because falling below that floor can trigger a compliance review and possible delisting, which is like failing a minimum grade and losing access to the public market; delisting can reduce liquidity, visibility and the ability to raise capital.
Bid Price Requirement regulatory
"regained compliance with Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”)"
A bid price requirement is a rule that specifies the minimum price a buyer must offer per share when making an official purchase proposal, tender offer, auction bid, or similar transaction. It matters to investors because it sets a floor for negotiations and valuation—like a reserve price in an auction—ensuring bids meet regulatory, contract or market standards and helping shareholders and markets judge whether an offer is fair or likely to succeed.
Nasdaq Global Select Market market
"continued inclusion on The Nasdaq Global Select Market pursuant to the Bid Price Requirement"
A Nasdaq Global Select Market listing is the highest tier of stocks on the Nasdaq exchange, reserved for companies that meet the strictest financial, reporting and governance standards. For investors, it acts like a premium quality label—signaling larger, more transparent and better-governed companies that tend to offer greater liquidity and lower perceived risk compared with lower-tier listings, making it easier to buy, sell and evaluate shares.
Listing Qualifications Department regulatory
"received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC"
A listing qualifications department is the part of a stock exchange that checks whether a company meets the exchange’s rules for being listed and staying listed. Think of it as a gatekeeper or building inspector: it reviews financial statements, disclosure practices and corporate governance, flags problems and can require fixes or remove a company’s shares. Investors care because its decisions affect whether a stock remains tradable and how much trust to place in a company’s reporting.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
false 0001162194 0001162194 2026-06-05 2026-06-05
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): June 5, 2026

 

 

Standard BioTools Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-34180   77-0513190

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification Number)

50 Milk Street, 10th Floor

Boston, Massachusetts 02109

(Address of principal executive offices and zip code)

(650) 266-6000

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol

  

Name of each exchange
on which registered

Common stock, $0.001 par value per share   LAB   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

Item 8.01 Other Events.

On June 5, 2026, Standard BioTools Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it has regained compliance with Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”).

As previously reported, on April 20, 2026, the Company received written notice from the Staff of Nasdaq notifying the Company that, because the closing bid price for the Company’s common stock, par value $0.001 per share, had fallen below $1.00 per share for 30 consecutive business days, the Company no longer met the minimum bid price requirement for continued inclusion on The Nasdaq Global Select Market pursuant to the Bid Price Requirement. This matter is now closed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:   June 5, 2026
STANDARD BIOTOOLS INC.
By:  

/s/ Alex Kim

Name:   Alex Kim
Title:   Chief Financial Officer

Source: View Original Filing on SEC EDGAR

FAQ

What did Standard BioTools Inc. (LAB) announce regarding its Nasdaq listing?

Standard BioTools Inc. announced it has regained compliance with Nasdaq’s minimum bid price rule. Nasdaq’s Listing Qualifications Staff notified the company on June 5, 2026, that it now meets Listing Rule 5450(a)(1) and that the prior deficiency matter is closed.

Why was Standard BioTools Inc. (LAB) previously non-compliant with Nasdaq rules?

The company became non-compliant because its common stock’s closing bid price stayed below $1.00 per share for 30 consecutive business days. Nasdaq notified Standard BioTools on April 20, 2026, that it no longer met the minimum bid price requirement for the Nasdaq Global Select Market.

What is Nasdaq Listing Rule 5450(a)(1) mentioned by Standard BioTools (LAB)?

Nasdaq Listing Rule 5450(a)(1) is the minimum bid price requirement for continued listing on the Nasdaq Global Select Market. It generally requires a company’s common stock to maintain a bid price of at least $1.00 per share to remain in good standing.

Is the Nasdaq bid price compliance issue for Standard BioTools (LAB) now resolved?

Yes, Nasdaq has confirmed the matter is resolved. On June 5, 2026, Nasdaq’s Listing Qualifications Staff informed Standard BioTools that it had regained compliance with the bid price requirement and that the earlier deficiency notice has been closed.

Does Standard BioTools (LAB) remain listed on the Nasdaq Global Select Market?

Standard BioTools’ common stock continues to trade on the Nasdaq Global Select Market. After regaining compliance with the minimum bid price rule, the company’s shares remain listed under the trading symbol LAB without ongoing bid price deficiency issues.

Filing Exhibits & Attachments

3 documents

Other Documents